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Abstract
Purpose
To examine the cross sectional and longitudinal relationship between cardiovascular risk
factors and age-related macular degeneration (AMD) in a large British cohort study.
Methods
The EPIC Norfolk Eye study is nested in a larger prospective cohort study. Data on cardio-
vascular risk factors were collected at baseline (1993-1997) and follow up (2006-2011) via
clinical examination, validated lifestyle questionnaires and serum blood samples. AMD was
ascertained using standardised grading of fundus photographs at the follow up. Logistic
regression was used to examine associations between baseline and follow up risk factors
with AMD.
Results
5,344 pairs (62.0% of total 8623) of fundus photographs were of sufficient quality for grading
of AMD in participants with mean age of 67.4 years old (range 44-91) at diagnosis. There
were 28 cases of late AMD (0.5%, 95% confidence interval (CI)=0.3-0.8%) and 645 cases
of early AMD (12.1%, 95%CI=11.2-13.0.%). In multivariable analysis, older people with
higher levels of baseline high density lipoprotein- cholesterol (HDL-C ) and C-reactive pro-
tein (CRP) were more likely to have any signs of AMD, after adjusting for sex, education,
smoking, and systolic blood pressure. In cross sectional analysis, only older age and higher
HDL were significantly associated with AMD.
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Conclusions
We have found that older age and higher levels of CRP and HDL-C were associated with
increased odds of AMD in this population in the longitudinal analysis, but older age and
HDL-C, not CRP was significantly associated with AMD in the cross sectional analysis. The
prevalence of AMD in this cohort was low compared to other cohorts in Europe, the US and
Australia, and probably reflects the some selection biases in follow up participation as well
as the low rate of smoking among our healthy participants.
Introduction
Age-related macular degeneration (AMD) is a progressive chronic eye disease and the leading
cause of low vision and blindness in developed countries.1 Early features include macular dru-
sen—localised deposits of extracellular debris in Bruch’s membrane. The disease can progress
to either geographic atrophy (“dry” AMD) or choroidal neovascularisation (“wet” AMD), both
of which can have devastating effects on central vision in late stages of the disease. AMD causes
approximately 5% of global blindness.[1] There are an estimated 71,000 new cases of late AMD
per year in the UK[2], and projections suggest that 3 million Americans over the age of 50 will
be affected by AMD by 2020[3]. Several genetic and environmental risk factors have been iden-
tified for AMD, with the strongest risk factor being older age. [4,5] Pooled findings from three
continents showed that the prevalence of AMD was 0.2% in those aged 55–64 years compared
to 13.1% in people aged 85 and over. [6]
Several studies have shown a consistent effect of cardiovascular risk factors on greater prev-
alence and incidence of AMD.[5,7–11] An adjusted analysis of results from the Beaver Dam,
the Blue Mountains and Rotterdam Eye Studies showed that current smokers were more than
twice as likely to develop late AMD than people who had never smoked. [4] Smoking is syner-
gistic with genetic risk factors to increase risk of the disease.[12] Other identified vascular asso-
ciations with AMD include cardiovascular disease,[10,13] stroke, [14] hypertension[10] and
inflammatory markers such as CRP. [15,16] The evidence for the association between serum
lipids and AMD is less consistent. The histological features of AMD suggest a possible role of
lipids in the aetiology of AMD. Drusen are predominantly composed of lipids and proteins,
and these deposits may interact with other lipids or proteins such as the complement complex
in the disease progression pathway.[17] Advanced AMD is associated with variants in the
hepatic lipase gene (LIPC) in the high-density lipoprotein (HDL) pathway.[18] However, the
inconsistent direction of effects between other HDL-associated single-nucleotide polymor-
phisms (SNPs) and AMD suggests a complex relationship between HDL and AMD. Epidemio-
logical studies have also provided mixed results, with studies showing no association[13],
increased risk[19–22,23]and a protective association[24–26] of higher HDL cholesterol levels
on AMD frequency.
In this study, we examined the cross sectional and longitudinal associations of cardiovascu-
lar risk factors and AMD.
Methods
The European Prospective Investigation into Cancer (EPIC) and Nutrition study is a 10 coun-
try collaborative cohort study investigating lifestyle and nutritional risk factors for cancer.
Detailed descriptions of the EPIC study methods and recruitment have been reported
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previously.[27,28,29] The baseline study cohort had lower smoking rates compared to national
British population samples, [27] but were otherwise comparable with regard to anthropometry
measures and blood pressure. The present study used exposure data collected from the first
health examination (1993–1997) and the third health examination (2006–2011). The eye data
were collected as part of the EPIC Norfolk Eye Study, which took place during the third round
of clinical examinations and included a full ophthalmic examination.36 The study was
approved by the Norfolk Local Research Ethics Committee and adhered to the Declaration of
Helsinki. All participants gave written informed consent.
The health examinations were carried out by trained nurses using standard operating proto-
cols. Systolic and diastolic blood pressure (sBP and dBP) were recorded as the mean of two
measurements separated in time, taken from the right arm with the participant seated for 5
minutes, using an Accutorr Plus blood pressure monitor (Mindray, Huntingdon, UK). Height
and weight were measured with participants dressed in light clothing and shoes removed. A
stadiometer was used to measure height to the nearest 0.1metre (m), and the Tanita body com-
position analyser model TBF 300s (Chasmors Ltd, London) was used to measure weight to the
nearest 100g. Body mass index (BMI) was calculated as weight in kg/height squared in m2. The
measurement of habitual physical activity and visual acuity (VA) in EPIC-Norfolk has been
previously described. The physical activity scale used has been validated against heart rate
monitoring with individual calibration in independent studies.[30]
Serum high-sensitivity CRP was measured using the Olympus AU640 Chemistry Immuno
Analyzer (Olympus Diagnostics, Watford, United Kingdom). Blood samples collected at base-
line examination were centrifuged at 2,100g for 15 minutes at 4°C, and serum samples were
kept frozen at −80°C until being thawed in 2008 for CRP assaying. Non-fasting serum total
and high-density lipoprotein- cholesterol (HDL-C) levels (mmol/l) were measured at both
health examinations using an RA 1000 Technicon analyser (Bayer Diagnostics, Basingstoke,
UK). Low-density lipoprotein-cholesterol (LDL-C) was determined using the Friedewald for-
mula. Social class was recorded according to the UK Registrar-General’s occupation-based
classification system; this was based on the participant’s last occupation if they were retired.
Educational level was recorded and classified into four groups according to the highest qualifi-
cation achieved. The four categories are less than O levels, O levels, A levels and degree or
above; O levels are qualifications gained at the end of secondary school after 11 years of school-
ing, and A levels after 13 years of schooling, with degrees obtained in university settings. Smok-
ing status was recorded as current, former and never. The EPIC Norfolk database was linked to
national hospital discharge data for Norfolk residents (ENCORE). Prevalent ischaemic heart
disease (IHD) and stroke in this study were ascertained through self-rated disease at baseline
(between 1993–1997), subsequent health examinations and any recorded episodes of IHD or
cardiovascular accident (CVA) from hospital episodes statistics (HES) data accumulated from
baseline until 2009.
Ascertainment of AMD
Digital fundus photographs of the optic disc and macula were taken using a TRC-NW6S non-
mydriatic retinal camera and IMAGEnet Telemedicine System (Topcon Corporation, Tokyo,
Japan) with a 10 megapixel Nikon D80 camera (Nikon Corporation, Tokyo, Japan) without
pharmacological dilation of the pupil. AMD was categorised by independent graders using a
modified Wisconsin protocol[31]. Main features for each image were assessed with standard-
ised photographs and included:
• Hard drusen size<63 μm, with more than ten hard drusen required to be present for the
lesion to be classified as present
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• Soft drusen of size125μm, with presence of one soft drusen sufficient for classification of
lesion to be present
• Geographic atrophy
• Choridal neovascularisation
• Retinal Pigment Epithelium (RPE) detachment
• Disciform scar
The predominant phenotype observed or the most severe lesion for each eye was used as the
final grading for that eye. Individual categorisation of AMD lesion was based on the more
severely affected eye.
Statistical Analysis
The data were initially explored through descriptive analysis of variables using t-tests for quan-
titative and χ2 test for categorical variables to compare different groups. AMD was analysed as
a binary variable with any AMD (including early disease) as the main outcome due to small
numbers of people with advanced AMD. Smokers were dichotomised into “never” and “ever”
for current and past smokers, due to the relatively small proportion of current smokers. A right
skew was evident in the CRP distribution. Therefore, CRP was categorised into clinically rele-
vant categories,1, 1.1–3, 3.1–10,10mg/L for initial descriptive and univariable analysis;
subsequently both categorical CRP and a log transformed continuous CRP were analysed sepa-
rately to maximise power to detect any differences. Univariable associations with any AMD as
the dependent variable were explored using logistic regression, tabulation and χ2 test. A step-
wise multivariable logistic regression model was used to examine the effect of detected and a
priori risk factors on AMD. Odds ratio for AMD were estimated per 1 standard deviation (SD)
increase in log transformed CRP. Indicator variables were used with all categorical variables in
the multivariable analysis, with interaction terms to test for evidence of effect modification. All
statistical analyses were conducted using STATA 12 (Statacorp, College Station, Texas, US).
Results
Of 8,623 participants examined in the EPIC Norfolk Eye study, retinal photographs were
obtained from 7,501 (87.0%) participants, of which 5,344 pairs of left and right eyes (62.0%)
were of sufficient quality for grading of AMD related fundus lesions. Participants with missing
or excluded photographs were older (70.8 years vs. 67.4 years p<0.01) and more likely to be
male (47.5% of those missing vs 43.1% with gradable photographs p<0.01), with lower levels
of education (28.4% of missing with no formal qualifications vs. 25.1% with graded photo-
graphs, p<0.01). Similar proportions of smokers did not have gradable photos compared to
those with grading (8.6% vs 9.4% missing p = 0.23). The mean age of the 5,344 included
Table 1. AMD diagnoses in worse eye.
Type Description N %
No AMD No AMD or hard drusen only 4671 87.4
Early AMD Soft drusen and/or pigmentary changes 645 12.1
Late AMD Presence of either geographic atrophy or exudative macular degeneration 28 0.5
Total 5344 100.0
AMD = age related macular degeneration
doi:10.1371/journal.pone.0132565.t001
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participants was 67.4 years (range 48.4–91.9 years), with 56.9% women. Women were younger
than men, with a mean age of 66.9 years compared to 68.1 years for men (p<0.01). Older men
and women both had higher BMI, sBP, dBP, LDL-C, total cholesterol, triglycerides, and CRP.
Older people were also more likely to have lower attained levels of education, to be less active,
and more likely to have never smoked. Older men and women also had lower levels of HDL-C,
though this was not statistically significant.
The study prevalence of AMD is shown in Table 1. There were 28 cases of late AMD (0.5%,
95% confidence interval (CI) = 0.3–0.8%) and 645 cases of early AMD (12.1%, 95%CI = 11.2–
13.0.%). The vision in the worse eye of the 28 participants categorised with late AMD was 6/60
or worse in 3 cases (10.7%), 6/18-6/60 in 4 participants (14.3%) and the remaining 21 people
(75.0%) had vision of 6/12 or better.
Univariable associations between both baseline and follow up clinical variables and AMD
diagnosed at the third health check are shown in Table 2. People with AMD were older and
more likely to be female; they were also more likely to have higher levels of sBP, HDL-C and
CRP measured at baseline. Similar associations were observed with follow up measurements.
There were additional cross sectional associations with AMD and higher levels of triglycerides
and physical activity.
Although the results indicated that people with AMD were more likely to be inactive,
the association was no longer statistically significant after adjusting for age and sex. At
baseline, 50 people reported strokes, with 152 recorded by third health examination, with no
evidence o f an association with AMD at any time point (0.5% of no AMD with stroke vs
0.9% AMD with stroke, p = 0.2 at baseline; 1.4% vs 1.6%, p = 0.6 in follow up). Similarly, 62
people had reported myocardial infarction at baseline with 161 at follow up with no associa-
tions observed with AMD (1.2% of no AMD with MI vs 0.9% AMD with MI, p = 0.5) at base-
line or at the third health examination (3.0% no AMD with MI vs 3.4% with AMD had MI,
p = 0.5).
In multivariable analysis shown in Table 3, older age was strongly associated with AMD,
with 8% increase in odds of AMD per year older, adjusting for sex, education, sBP, HDL, smok-
ing, and CRP. Higher sBP and female gender were no longer associated with AMD after adjust-
ing for covariables. Although higher serum triglycerides were associated with AMD at follow
up, it was not statistically significant in the final model, and removed due to its low impact on
final estimates. Education and smoking were included in the final model as recognised markers
of AMD risk, though no evidence of an association with AMD observed in this study sample.
Both continuous CRP (using natural logs, OR presented in table is the exponential of the esti-
mated coefficient) and HDL remained significantly associated with AMD in the final model
using baseline measurements, with 1 SD increase in log transformed CRP (equating to approxi-
mately 3 fold increase in CRP) increasing odds of AMD by 11%, and 0.5 mmol/L increase in
HDL increasing odds of AMD by 15%. In the final cross sectional model, CRP was not signifi-
cantly associated with AMD, with only age and HDL remaining as independent risk factors.
There was no evidence of an interaction with the categorical variables age (<60 vs>60), sex,
CRP categories, smoking, social class or education when interaction terms were used (all inter-
action tests p>0.05).
Discussion
In this community based study of 5344 older people, we found that higher levels of HDL and
CRP at baseline, but neither smoking nor other cardiovascular risk factors, were associated
with a higher occurrence of AMD. HDL was the only cardiovascular risk factor associated with
AMD in the cross sectional analysis.
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There was an overall low study prevalence of AMD, with only 12.6% (95%CI = 11.7–13.5%)
of participants with signs of AMD and 0.5% (95%CI = 0.3–0.7%) with geographic atrophy or
NV-AMD. This was lower than the prevalence reported in epidemiological studies in predomi-
nantly White populations of the United States (US), Australia and the Netherlands, where late
Table 2. Univariable associations between cardiovascular risk factors measured at baseline and follow up and AMD in 5344men and women.
Baseline (1993–1997) Follow up (2006–2011)
AMD No AMD p-value* AMD No AMD p-value
Age (years) 57.7 (7.7) 54. (7.2) <0.01 71.10 (7.7) 66.91 (7.5) <0.01
BMI (kg/m2) 25.89 (3.64) 25.75 (3.7) 0.38 26.88 (4.10) 26.81 (4.36) 0.66
WHR 0.83 (0.09) 0.84 (0.09) 0.37 0.89 (0.08) 0.89 (0.08) 0.82
Weight 71.86 (12.1) 72.87 (12.8) 0.06 73.14 (13.4) 74.66 (14.2) <0.01
Systolic Blood pressure (mmHg) 132.13 (16.9) 130.60 (16.4) 0.03 137.66 (17.3) 135.46 (16.6) <0.01
Diastolic Blood pressure (mmHg) 80.85 (10.5) 80.93 (10.8) 0.85 78.31 (9.07) 78.58 (9.30) 0.49
HDL-cholesterol (mmol/L) 1.49 (0.42) 1.44 (0.42) <0.01 1.58 (0.43) 1.50 (0.41) <0.01
LDL-cholesterol (mmol/L) 3.84 (1.03) 3.82 (0.98) 0.53 3.14 (0.99) 3.23 (1.00) 0.04
Cholesterol (mmol/L) 6.06 (1.13) 5.99 (1.08) 0.19 5.38 (1.12) 5.45 (1.14) 0.18
Triglycerides (mmol/L) 1.62 (0.94) 1.67 (1.02) 0.28 1.70 (0.93) 1.69 (0.92) <0.01
CRP (mg/L) 0.02 0.02
1.0 191 (41.0) 1617 (48.7) 103 (17.8) 721 (18.0)
1.1–3.0 174 (37.3) 1100 (33.1) 284 (49.0) 2199 (54.8)
3.0–10.0 85 (18.2) 520 (15.7) 165 (28.4) 917 (22.8)
10 16 (3.4) 83 (2.5) 28 (4.8) 175 (4.4)
Physical Activity 0.80 <0.01
Inactive 153 (22.7) 984 (21.1) 273 (41.2) 1584 (34.4)
Moderately inactive 198 (29.4) 1419 (30.4) 189 (28.5) 1401 (30.4)
Moderately active 175 (26.0) 1235 (26.4) 112 (16.9) 849 (18.4)
Active 147 (21.8) 1033 (22.1) 89 (13.4) 777 (16.8)
Smoking 0.17 0.32
Current 45 (6.7) 413 (8.9) 21 (3.2) 204 (4.4)
Former 262 (39.1) 1751 (37.6) 298 (45.0) 2058 (44.6)
Never 363 (54.2) 2488 (53.5) 344 (51.9) 2349 (51.0)
Sex 0.009
Male 259 (38.5) 2046 (43.8)
Female 414 (61.5) 2625 (56.2)
Social Class 0.94
Non-manual 439 (65.8) 3050 (66.0)
Manual 228 (34.2) 1573 (34.0)
Education 0.08
Less than O level 196 (29.1) 1143 (24.5)
O Level 80 (11.9) 580 (12.4)
A Level 282 (41.9) 2111 (45.2)
Degree 115 (17.1) 836 (17.9)
Total
AMD = age-related macular degeneration, BMI = Body mass Index, HDL = high density lipoprotein, LDL = low density lipoprotein, CRP = C = reactive
protein
*p-value from t-test or χ2 test for association between risk factor and AMD
Data presented as n(%) for categorical variables, and mean (SD) for continuous variables.
doi:10.1371/journal.pone.0132565.t002
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AMD (geographic atrophy or neovascular AMD) was observed in 1.6, 1.9 and 1.7% respec-
tively.[32–34] The lower prevalence in our study was likely due to a selection bias from healthy
survivors of a longitudinal study who were able to attend a clinic examination; the implications
of this will be discussed further.
The observed association with baseline CRP was consistent with findings from a review of
observational studies by Hong et al.,[16] where the pooled OR from the meta-analysis of stud-
ies examining low vs high levels of CRP (commonly<1.1 vs3mg/L) using both early and late
AMD as an outcome was 1.31 (95% CI = 1.04–1.65), which is similar to our results (OR = 1.11
95%CI = 1.00–1.23 for a nearly 3 fold increase). There is substantial evidence to support an
inflammatory mechanism in the pathogenesis of AMD. A variety of raised inflammatory mark-
ers and genes in the complement pathway, including complement factor H (CFH),[35,36] com-
plement factor B/complement component 2 (CFB/C2),[37] complement 3 (C3),[38] and
complement factor I (CFI)[39] are associated with increased risk of AMD. In the cross sectional
examination, CRP was no longer associated with AMD after adjusting for age and sex. These
differing associations are in line with findings from Hong’s meta-analysis stratified by study
design, where pooled analysis of population based longitudinal studies showed a significant
association with AMD (pooled OR = 2.20, 95%CI = 1.24–3.91) though the population based
cross sectional studies did not (pooled OR = 1.22 (0.93–1.60). The authors suggested that
underlying differences in ascertainment of AMD were the main reason for the differences; our
results indicate otherwise. One possible explanation is that different levels of CRP mark differ-
ent stages of the disease process, with inflammatory processes contributing to the initial onset
or stages of disease and lower levels of inflammation in established disease.
Previous reports on the association between HDL and AMD have been inconsistent, with
studies showing positive, inverse or no association.[13,19,24] We found that higher levels of
Table 3. Multivariable logistic regression results for odds of AMD detected in Third health examination for variables collected at baseline and fol-
low up.
Baseline Follow up
OR* 95% CI p-value‡ OR* 95% CI p-value‡
Age per year 1.08 1.06 1.09 <0.01 1.07 1.06 1.09 <0.01
Female 1.21 0.96 1.54 0.11 1.18 0.93 1.50 0.18
Education Level 0.92 0.84
Less than O level Ref Ref
O level 1.00 0.70 1.42 1.00 0.94 0.66 1.34 0.73
A level 0.95 0.74 1.22 0.68 0.89 0.69 1.15 0.36
Degree 1.05 0.76 1.43 0.79 0.94 0.68 1.30 0.71
Systolic blood pressure per 20mmHg 0.94 0.83 1.06 0.31 1.03 0.92 1.17 0.59
HDL cholesterol per 0.5mmol/L 1.15 1.01 1.30 0.03 1.26 1.10 1.43 <0.01
Smoking 0.95 0.98
Current Ref Ref
Former 1.02 0.67 1.53 0.94 0.95 0.54 1.68 0.86
Never 0.98 0.66 1.47 0.93 0.95 0.54 1.67 0.85
CRP†(mg/L) 1.11 1.00 1.23 0.04 1.10 1.00 1.22 0.08
OR = Odds ratio, CI = conﬁdence interval, HDL = High density lipoprotein, CRP = C reactive protein
*All variables were mutually adjusted in one regression model;
‡p-value from Wald test or likelihood ratio test for categorical variables.
†Per 1 SD increase in log transformed CRP (equating to approximately 3 fold increase in CRP)
doi:10.1371/journal.pone.0132565.t003
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HDL at baseline (and likely lower cardiovascular risk) were associated with higher odds of
AMD (OR = 1.37, 95% CI = 1.05–1.78), but there was no association between AMD and LDL;
this supports findings from the POLA study that found a 50% increased risk with higher levels
of HDL.[20] Pooled data from the three epidemiological studies with predominantly White
populations did not find a significant association with HDL (OR = 1.00, 95%CI = 0.98–1.03).
[4] These conflicting findings are reflected in the complex associations with HDL pathway
genes, where alleles of the LIPC gene that raise HDL and alleles of the CEPT genes that
decrease HDL have both been implicated in AMD aetiology.[18] It is possible that observed
differences might be due to differences in the background environmental and genetic risk in
the study populations. HDL has heterogeneous structure and functions, with normal functions
including cholesterol lowering and anti-inflammatory properties. However, inflammation can
modify the structure of HDL and lowers its ability to reduce peripheral cholesterol and it is
transformed to a pro-inflammatory particle. [40] Recent studies have shown that high levels of
HDL are associated with an increased risk of recurrent coronary events in patients with previ-
ous infarcts.[41] Furthermore, follow up of this cohort showed that those with high levels of
HDL and CRP at baseline were at increased risk of incident CVD. [42] The interaction between
baseline CRP and HDL could explain our results. However, there was no evidence of a statisti-
cal interaction between baseline HDL and dichotomised CRP (<3 vs> = 3mmol/l) levels for
risk of AMD, though this does not preclude a potential effect due to the low power of the inter-
action test.
We did not detect an association between smoking and AMD, which contrasts strongly
with several epidemiological studies and meta- analyses where smoking is associated with a
two fold increase in neovascular AMD risk.[4] Epidemiological studies have shown stronger
effects with current smokers compared to past smokers.[7,10] Pooled analysis from the Beaver
Dam, Blue Mountains and Rotterdam eye studies showed a longitudinal association between
current smokers at baseline and the 5–6 year incidence and progression of early AMD.[4]
Overall, 18.5% of participants with follow up in the 3 studies were smokers at baseline com-
pared to 8.6% in our selected study population. Assuming an OR of 2.3, the current study pro-
portions of late AMD and current smokers would have only had 16% power to detect an effect.
There were limitations in our study. The present study was an average 17 year follow up of a
larger longitudinal study, with healthier survivors and a lower frequency of risk factors and
outcomes, which would reduce the likelihood of detecting true associations. People with AMD
or cardiovascular disease were also less likely to attend due to relatively poor health and/or
vision. However, both factors resulting in truncation of the distribution would be likely to
attenuate any underlying associations. In addition to reduced power, there may also have been
measurement error in assessment of AMD. However, the use of a standardised objective grad-
ing system would have mitigated potential systematic errors. We also used non-mydriatic pho-
tographs, and 28.8% of photos were of insufficient quality for grading. Those with ungradable
photos were older and more likely to have AMD, further reducing power. The predominant
phenotype approach may have reduced detection of small differences between clinical sub-
types, but would have increased reliability of grading outcomes. We were only able to ascertain
the outcome in the follow up study and cannot exclude prevalent cases at baseline, however, as
there was a very low prevalence of late AMD In the follow up, there were unlikely to have been
many cases of AMD at baseline. Furthermore, excluding late cases does not alter the interpreta-
tion of the final model, indicating that baseline risk factors were likely to have been present
prior to disease, and also the associations detected relate primarily to early AMD. Additional
cardiovascular risk factors known to be associated with AMD such as dietary intake of oily fish
and intake of leafy green vegetables were not included in this analysis because it was beyond
the scope of the current investigation, which focused on more proximal markers of
Cardiovascular Risk Factors and Age Related Macular Degeneration
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cardiovascular risk. Further research into dietary factors and AMD are important because they
are modifiable risk factors and could inform public health action in the prevention of AMD.
In summary, we have found that older age, higher baseline and follow up levels of HDL, and
baseline CRP were associated with increased odds of AMD. The prevalence of AMD in this
cohort was low compared to other cohorts in Europe, the US and Australia, and possibly
reflects healthier participants as well as the low rate of smoking among our participants.
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